Official ESCRS | European Society of Cataract & Refractive Surgeons
Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

Posters

Search Title by author or title

Pseudoexfoliation glaucoma and cataract: phacotrabeculectomy versus trabeculectomy

Poster Details

First Author: M.Saricaoglu TURKEY

Co Author(s):    A. Karakurt   M. Hamurcu   S. Ekicier              

Abstract Details

Purpose:

The aim of this study was to evaluate the surgical outcome of trabeculectomy or phacotrabeculectomy surgery, according to the degree of visual acuity that affected with cataract, in the patients with the diagnosis of pseudoexfoliative glaucoma and cataract.

Setting:

Ankara Numune Training and Research Hospital

Methods:

Twenty-three eyes of 22 patients (group 1) undergoing trabeculectomy surgery and 26 eyes of 26 patients (group 2) undergoing phacotrabeculectomy surgery were included in the study. Visual acuity, intraocular pressures (IOP), fundus examinations and c/d ratios, and number of glaucoma medications used before and after the operation were recorded. The results were compared statistically. The statistical significance was accepted as p <0.05.

Results:

The mean preoperative IOP was 31.5 �Â�± 13.8 mmHg in group 1 and 29.6 �Â�± 6.3 mmHg in group 2, postoperative last control examinations were 14.0 �Â�± 4.3 mmHg and 14.1 �Â�± 3.4 mmHg respectively. The mean number of glaucoma medication was 1.5�Â�±1.3 in group 1 and 1.7�Â�±1.1 in group 2, and after surgery that was 0.05�Â�±0.2 and 0.15�Â�±0.4 respectively. Compared with preoperative and postoperative data, IOP and the number of glaucoma medications were decreased significantly within groups (p<0.05). There was no statistically significant difference between the groups in terms of IOP decrease and the number of medications (p>0.05).

Conclusions:

In pseudoexfoliation glaucoma, both two methods were found to be effective in glaucoma control, whereas phacotrabeculectomy was an advantage in terms of increased visual acuity.

Financial Disclosure:

NONE

Back to Poster listing